MS
DMK

Maven Securities’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Maven Securities’s Portfolio DMK Stock Details DMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-14,286
Closed -$795K – 913
2020
Q3 		$795K Buy
+14,286
New +$847K 0.07% 290

Other funds holding DMK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RW
RVW Wealth Los Angeles, California $1.52B AUM 23.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Maven Securities's DMK Position: Q4 2020 in Review

Maven Securities sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q4 2020, closing a stake of 14,286 shares — an estimated $795K sold.

Maven Securities first reported a position in DMK in Q3 2020 and held it in 1 quarter. The position peaked at $795K in Q3 2020. 41 funds tracked by Wall St. Rank hold DMK as of Q4 2020.

  • Maven Securities reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q4 2020 after selling out during the quarter.
  • Maven Securities sold 14,286 DMK Pharmaceuticals Corporation Common Stock shares in Q4 2020, an estimated $795K.
  • Maven Securities first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q3 2020 and held it in 1 quarter.
  • Maven Securities's DMK Pharmaceuticals Corporation Common Stock position peaked at $795K in Q3 2020.
  • 41 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q4 2020.

Based on Maven Securities's 13F filing for Q4 2020, filed 12 Feb 2021.